Pfizer And BioNTech Claim COVID-19 Vaccine Success
Interim Analysis Finds Vaccine 90% Effective, EUA Filing Expected Late November
Pfizer and BioNTech have produced better than expected efficacy results - but will wait for safety data before filing later this month. 
